NeuBase Therapeutics, Inc. (NBSE) Financial Statements

NeuBase Therapeutics, Inc. (NBSE) files with the U.S. Securities and Exchange Commission under CIK 0001173281. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2023

Net Income: -$13.73 million

Latest periodic SEC filing: Nov 9, 2023. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for NBSE in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History